VERLANDE, Amandine, Michaela KRAFČÍKOVÁ, David POTĚŠIL, Lukáš TRANTÍREK, Zbyněk ZDRÁHAL, M. ELKALAF, J. TRNKA, Karel SOUČEK, N. RAUCH, J. RAUCH, W. KOLCH and Stjepan ULDRIJAN. Metabolic stress regulates ERK activity by controlling KSR-RAF heterodimerization. EMBO reports. Hoboken: Wiley-Blackwell, 2018, vol. 19, No 2, p. 320-336. ISSN 1469-221X. Available from: https://dx.doi.org/10.15252/embr.201744524.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Metabolic stress regulates ERK activity by controlling KSR-RAF heterodimerization
Authors VERLANDE, Amandine (250 France, belonging to the institution), Michaela KRAFČÍKOVÁ (703 Slovakia, belonging to the institution), David POTĚŠIL (203 Czech Republic, belonging to the institution), Lukáš TRANTÍREK (203 Czech Republic, belonging to the institution), Zbyněk ZDRÁHAL (203 Czech Republic, belonging to the institution), M. ELKALAF (203 Czech Republic), J. TRNKA (203 Czech Republic), Karel SOUČEK (203 Czech Republic, belonging to the institution), N. RAUCH (372 Ireland), J. RAUCH (372 Ireland), W. KOLCH (372 Ireland) and Stjepan ULDRIJAN (203 Czech Republic, guarantor, belonging to the institution).
Edition EMBO reports, Hoboken, Wiley-Blackwell, 2018, 1469-221X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 8.383
RIV identification code RIV/00216224:14110/18:00100832
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.15252/embr.201744524
UT WoS 000424166400015
Keywords in English cell cycle arrest; cell survival; melanoma; metabolic stress; RAF-ERK signaling
Tags 14110513, EL OK, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 6/3/2019 13:35.
Abstract
Altered cell metabolism is a hallmark of cancer, and targeting specific metabolic nodes is considered an attractive strategy for cancer therapy. In this study, we evaluate the effects of metabolic stressors on the deregulated ERK pathway in melanoma cells bearing activating mutations of the NRAS or BRAF oncogenes. We report that metabolic stressors promote the dimerization of KSR proteins with CRAF in NRAS-mutant cells, and with oncogenic BRAF in BRAF(V600E)-mutant cells, thereby enhancing ERK pathway activation. Despite this similarity, the two genomic subtypes react differently when a higher level of metabolic stress is induced. In NRAS-mutant cells, the ERK pathway is even more stimulated, while it is strongly downregulated in BRAF(V600E)-mutant cells. We demonstrate that this is caused by the dissociation of mutant BRAF from KSR and is mediated by activated AMPK. Both types of ERK regulation nevertheless lead to cell cycle arrest. Besides studying the effects of the metabolic stressors on ERK pathway activity, we also present data suggesting that for efficient therapies of both genomic melanoma subtypes, specific metabolic targeting is necessary.
Links
GA14-12166S, research and development projectName: Regulace dráhy nádorového supresoru p53 novými vazebnými partnery onkogenů Mdm2 a Mdm4
Investor: Czech Science Foundation
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/0810/2016, interní kód MUName: Molekulární a buněčná biologie
Investor: Masaryk University, Category A
PrintDisplayed: 17/7/2024 07:13